Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company's novel und…
USD43.21+0.10%vs prev. close
Performance
1W
-7.96%
1M
+9.10%
3M
-17.74%
1Y
+43.68%
YTD
-1.92%
Valuation
P/E
—
EPS TTM
-3.23
Dividend yield
—
Size and risk
Market cap
$5.3B
Beta
0.79
Price history
SRRK price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Scholar Rock
SRRK
Biotechnology
Mkt cap (USD bn)
5.3
P/E
—
Div yld
—
1W
-8.0%
1M
+9.1%
3M
-17.7%
6M
-12.4%
1Y
+43.7%
YTD
-1.9%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Scholar Rock
SRRK
Biotechnology
5.3
—
—
-8.0%
+9.1%
-17.7%
-12.4%
+43.7%
-1.9%
Subscribe to Equity Analytics to compare SRRK with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.